Welcome Dr. Jennifer Wortmann!
January 21, 2025
Our News
Welcome Dr. Melissa Smigelsky!
January 21, 2025
Welcome Dr. Nieuwsma!
January 21, 2025
Dr. Julia Riddle speaks with TODAY about PMDD treatment
January 7, 2025
Welcome Dr. Lisa Herrera!
December 9, 2024
Dr. Zev Nakamura speaks with NBC News about undiagnosed depression in cancer patients
December 4, 2024
Psychiatry Impact Report 2024
November 22, 2024
UNC Startup Redefining Mental Health Treatment with Eye-Tracking Technology
November 14, 2024
Multisystem stress response biotypes: a precision psychiatry approach to identifying and treating multidimensional risk factors for anhedonia in adolescence
November 13, 2024
Adolescence is a critical period of developmental changes in neurobiological and psychological systems, rendring it both a period of vulnerability for the emergence of risk factors associated with psychopathology and a period of opportunity for the implementation of targeted prevention and interventions. Anhedonia (i.e., the reduced ability to anticipate or...
Neurosteroid [3α,5α]3-hydroxypregnan-20-one inhibition of chemokine monocyte chemoattractant protein-1 in alcohol-preferring rat brain neurons, microglia, and astroglia
November 13, 2024
Background: Neuroimmune dysfunction in alcohol use disorder (AUD) is associated with activation of myeloid differentiation primary response 88 (MyD88)-dependent Toll-like receptors (TLR) resulting in overexpression of the chemokine monocyte chemoattractant protein-1 (MCP-1/CCL2). MCP-1 overexpression in the brain is linked to anxiety, higher alcohol intake, neuronal death, and activation of microglia...